secwatch / observer
8-K filed April 16, 2026, 7:59 PM ET ticker SYRE CIK 0001636282
other material confidence high sentiment neutral materiality 0.70

Spyre Therapeutics raises ~$463.5M in underwritten public offering of 7.475M shares at $62.00/share

Spyre Therapeutics, Inc.

item 1.01item 9.01

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001628280-26-025508
form_type
8-K
ticker
SYRE
cik
0001636282
company_name
Spyre Therapeutics, Inc.
filed_at
2026-04-16T23:59:59+00:00
discovered_at
2026-05-14T18:02:32.632342+00:00
generated_at
2026-05-15T05:47:18.729716+00:00
sec_items
["1.01", "9.01"]
event_type
other_material
sentiment
neutral
materiality_score
0.7
calibrated_materiality_score
0.7
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001628280-26-025508
json_url
https://secwatch.observer/filing/0001628280-26-025508.json
markdown_url
https://secwatch.observer/filing/0001628280-26-025508.md
text_url
https://secwatch.observer/filing/0001628280-26-025508.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/1636282/000162828026025508/0001628280-26-025508-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/1636282/000162828026025508/syre-20260414.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null
JSON Markdown Plain text

Source-grounded claims

d9ca047cbe049c56a5dfea7b8af40c69f6176cf6

Spyre Therapeutics, Inc. entered into Underwriting Agreement with Jefferies LLC, Goldman Sachs & Co. LLC, Evercore Group L.L.C. and Guggenheim Securities, LLC, as the representatives of the underwriters valued at approximately $463.5 million (effective 2026-04-14).

The Underwriting Agreement contains customary representations and warranties, agreements and obligations, conditions to closing and termination provisions.

SEC 8-K Item 1.01/1.02 confidence 0.9 SEC evidence

Comparable filings

CITR

CitroTech exchanges all Series A Preferred for Series C Convertible; BoltRock gets board rights

CitroTech Inc. June 1, 2026, 4:15 PM ET other_material Items 1.01, 3.02, 9.01

same fact type: material_agreement same SEC item: 1.01, 9.01 same event type: other_material similar materiality

This filing

The Underwriting Agreement contains customary representations and warranties, agreements and obligations, conditions to closing and termination provisions.

Comparable filing

On May 28, 2026, CitroTech Inc., a Wyoming corporation (the “Company”), entered into Stock Exchange and Stockholders Agreements (the “Exchange Agreements”) with the holders (the “Holders”) of the Company’s outstanding Series A Preferred Stock

Filing page SEC filing

LTRX

Lantronix prices $30M common stock offering at $7.20/share; net proceeds ~$32.3M

LANTRONIX INC June 1, 2026, 4:15 PM ET other_material Items 1.01, 7.01, 9.01

same fact type: material_agreement same SEC item: 1.01, 9.01 same event type: other_material similar materiality

This filing

The Underwriting Agreement contains customary representations and warranties, agreements and obligations, conditions to closing and termination provisions.

Comparable filing

On May 29, 2026, Lantronix, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Needham & Company, LLC and Canaccord Genuity LLC, as underwriters (together, the “Underwriters”), pursuant to which the Company agreed to sell, and the Underwriters agreed to purchase, 4,166,667 shares (the “Firm Shares”) of the Company’s common stock

Filing page SEC filing

PUBC

Purebase to receive 20% of net proceeds from CoreTer mining deal; waives corporate opportunities

Purebase Corp June 1, 2026, 3:42 PM ET other_material Items 1.01, 9.01

same fact type: material_agreement same SEC item: 1.01, 9.01 same event type: other_material similar materiality

This filing

The Underwriting Agreement contains customary representations and warranties, agreements and obligations, conditions to closing and termination provisions.

Comparable filing

On May 26, 2026, Purebase Corporation (the “Company”) entered into a binding Memorandum of Understanding (the “MOU”) with CoreTer LLC, a Nevada limited liability company (“CoreTer”), pursuant to which the Company will be entitled to 20% of the net proceeds received by CoreTer under an Exclusive Mining Option and Development Agreement, dated March 19, 2026, between CoreTer and Dexter Mining LLC.

Filing page SEC filing

CPSH

CPS Technologies closes $9.6M registered direct offering of 1.2M shares at $8.00/share

CPS TECHNOLOGIES CORP/DE/ June 1, 2026, 9:35 AM ET other_material Items 1.01, 5.03, 8.01, 9.01

same fact type: material_agreement same SEC item: 1.01, 9.01 same event type: other_material similar materiality

This filing

The Underwriting Agreement contains customary representations and warranties, agreements and obligations, conditions to closing and termination provisions.

Comparable filing

On May 27, 2026, CPS Technologies Corp. (the “Company”) entered into securities purchase agreements (the “Purchase Agreements”) with certain institutional investors (the “Investors”) for the sale by the Company of 1,200,000 shares (the “Shares”) of its Common Stock, par value $0.01 per share (“Common Stock”), in a registered direct offering (the “Offering”), at a purchase price of $8.00 per share.

Filing page SEC filing

BNAI

BEN invests $1M in Accelevate, signs exclusive Mexico reseller and global deal

Brand Engagement Network Inc. May 11, 2026, 7:59 PM ET other_material Items 1.01, 7.01, 9.01

same fact type: material_agreement same SEC item: 1.01, 9.01 same event type: other_material similar materiality

This filing

The Underwriting Agreement contains customary representations and warranties, agreements and obligations, conditions to closing and termination provisions.

Comparable filing

On May 7, 2026, following the successful completion of due diligence, entered into two definitive Reseller Agreements (the “Commercial Agreements”) with Accelevate.

Filing page SEC filing

SAGU

Shreya Acquisition Group closes $110M IPO, 11M units at $10 each on NYSE

Shreya Acquisition Group May 11, 2026, 7:59 PM ET other_material Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01

same fact type: material_agreement same SEC item: 1.01, 9.01 same event type: other_material similar materiality

This filing

The Underwriting Agreement contains customary representations and warranties, agreements and obligations, conditions to closing and termination provisions.

Comparable filing

Private Units Subscription Agreement, dated May 6, 2026, by and between the Company and the Sponsor, a copy of which is attached as Exhibit 10.4 and incorporated herein by reference

Filing page SEC filing

CLRB

Cellectar raises ~$35M via stock/warrant offering; reports positive 12-mo Phase 2b WM data

Cellectar Biosciences, Inc. May 8, 2026, 7:59 PM ET other_material Items 1.01, 3.02, 8.01, 9.01

same fact type: material_agreement same SEC item: 1.01, 9.01 same event type: other_material similar materiality

This filing

The Underwriting Agreement contains customary representations and warranties, agreements and obligations, conditions to closing and termination provisions.

Comparable filing

pursuant to an additional securities purchase agreement with certain members of the executive management team of the Company (the “Management Purchase Agreement”

Filing page SEC filing

XRN

Chiron Real Estate enters $100M preferred equity deal with Maewyn XRN LP

Chiron Real Estate Inc. May 8, 2026, 7:59 PM ET other_material Items 1.01, 3.02, 9.01

same fact type: material_agreement same SEC item: 1.01, 9.01 same event type: other_material similar materiality

This filing

The Underwriting Agreement contains customary representations and warranties, agreements and obligations, conditions to closing and termination provisions.

Comparable filing

In connection with the Private Placement, on May 6, 2026, the Company and the Purchasers entered an Investor Rights Agreement.

Filing page SEC filing

Source: SEC EDGAR
accession 0001628280-26-025508
view filing index on sec.gov
view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.